Actigraphy Sensors & PSG Devices Market: A Growing Frontier in Sleep Monitoring

The global actigraphy sensors & PSG devices market is valued at US$ 1.2 billion in 2023 and is expected to reach a size of US$ 2 billion by 2033-end. Global demand for actigraphy sensors & PSG devices is predicted to increase at a CAGR of 5.2% from 2023 to 2033.

The global Actigraphy Sensors and Polysomnography (PSG) Devices market has witnessed substantial growth over the past decade as the importance of sleep monitoring and sleep-related disorders has gained recognition. Actigraphy sensors and PSG devices play a pivotal role in diagnosing and managing sleep disorders, ultimately improving the overall quality of life for millions of individuals worldwide. In this article, we will delve into the Actigraphy Sensors and PSG Devices market, exploring its growth drivers, technological advancements, key players, and future prospects.

Get a FREE Sample Copy of Report (Including TOC, List of Tables & Figures, Chart) :

Market Growth Drivers

Rising Awareness of Sleep Disorders: Increased awareness of the adverse effects of sleep disorders on overall health has been a significant driver for the Actigraphy Sensors and PSG Devices market. Sleep disorders, such as sleep apnea, insomnia, and restless leg syndrome, can lead to a range of health issues, including cardiovascular diseases, obesity, and impaired cognitive function. This growing awareness has spurred the demand for diagnostic tools like actigraphy sensors and PSG devices.

Aging Population: The global demographic shift towards an aging population has also contributed to the market’s growth. Elderly individuals are more prone to sleep disorders and require regular monitoring. Actigraphy sensors and PSG devices have become indispensable in the care and management of geriatric patients, leading to an expanded customer base.

Technological Advancements: Advancements in sensor technology and data analytics have revolutionized the Actigraphy Sensors and PSG Devices market. Miniaturization, improved accuracy, and wireless connectivity have made these devices more user-friendly and accessible. Wearable actigraphy sensors, for instance, can continuously monitor sleep patterns without causing discomfort to the user.

Increasing Demand for Home-Based Sleep Monitoring: The preference for home-based sleep monitoring over in-lab studies has surged. PSG devices are now available in portable and user-friendly forms, allowing individuals to monitor their sleep in the comfort of their homes. This trend is expected to boost the adoption of PSG devices in the coming years.

Key Market Players

ResMed: ResMed is a prominent player in the Actigraphy Sensors and PSG Devices market. The company offers a wide range of sleep-related solutions, including PSG devices and cloud-based sleep management platforms. Their commitment to innovation and patient-centric solutions has solidified their position in the market.

Philips Healthcare: Philips Healthcare is another major player, known for its comprehensive portfolio of sleep solutions. Their actigraphy sensors and PSG devices are renowned for their accuracy and ease of use. Philips’ focus on improving patient outcomes has earned them a strong market presence.

Natus Medical Incorporated: Natus Medical is a leading manufacturer of PSG devices and actigraphy sensors. They are known for their advanced technology and comprehensive sleep monitoring solutions, catering to both clinical and home-based settings.

Compumedics Limited: Compumedics specializes in cutting-edge PSG devices and actigraphy sensors. Their products are widely used in research institutions, hospitals, and sleep clinics, reflecting their commitment to providing high-quality solutions.

Future Prospects

The Actigraphy Sensors and PSG Devices market is poised for continued growth in the coming years. Several factors contribute to this optimistic outlook:

Integration with Telemedicine: The ongoing expansion of telemedicine services is likely to integrate sleep monitoring seamlessly into virtual healthcare. This will broaden the reach of actigraphy sensors and PSG devices, making them more accessible to remote populations.

Focus on Personalized Medicine: Advancements in data analytics and artificial intelligence are enabling personalized sleep management plans. PSG devices, in combination with AI-driven algorithms, can provide tailored recommendations for improving sleep quality, which is a trend likely to gain momentum.

Global Prevalence of Sleep Disorders: Sleep disorders are not limited to specific regions or demographics. The global prevalence of sleep disorders, coupled with increasing awareness, will drive the demand for actigraphy sensors and PSG devices across the world.

Research and Development: Ongoing research and development efforts are expected to result in even more advanced and cost-effective devices. This will further increase their accessibility and utility, bolstering market growth.

Get Customization on this Report for Specific Research Solutions:


The Actigraphy Sensors and PSG Devices market is at the forefront of sleep monitoring technology, with a promising future ahead. Increased awareness of sleep disorders, technological advancements, and the aging population are driving market growth. Key players like ResMed, Philips Healthcare, Natus Medical Incorporated, and Compumedics Limited continue to innovate, offering comprehensive solutions for sleep monitoring. As telemedicine and personalized medicine gain traction, these devices are expected to become more accessible and integral to healthcare, ultimately improving the quality of sleep and overall health for individuals worldwide.

About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, industrial goods to even the most niche categories. 80% of Fortune 1000s trust us in critical decision making.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: [email protected]